The Latest Trading Price of IOL Chemicals & Pharmaceuticals Ltd is ₹ 95.95 as of 06 May 15:30
. The P/E Ratio of IOL Chemicals & Pharmaceuticals Ltd changed from 12.4 on March 2022 to 17.8 on March 2025 . This represents a CAGR of 9.46% over 4 yearsThe P/E Ratio of Ishita Drugs & Industries Ltd changed from 0 on March 2022 to 0 on March 2025 . This represents a CAGR of 0.0% over 4 years The Market Cap of IOL Chemicals & Pharmaceuticals Ltd changed from ₹ 2077 crore on March 2022 to ₹ 1796 crore on March 2025 . This represents a CAGR of -3.56% over 4 yearsThe Market Cap of Ishita Drugs & Industries Ltd changed from ₹ 0 crore on March 2022 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 4 years The revenue of IOL Chemicals & Pharmaceuticals Ltd for the Dec '25 is ₹ 585.68 crore as compare to the Sep '25 revenue of ₹ 574.41 crore. This represent the growth of 1.96% The revenue of Ishita Drugs & Industries Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of IOL Chemicals & Pharmaceuticals Ltd for the Dec '25 is ₹ 51.36 crore as compare to the Sep '25 ebitda of ₹ 63.96 crore. This represent the decline of -19.7% The ebitda of Ishita Drugs & Industries Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of IOL Chemicals & Pharmaceuticals Ltd changed from ₹ 29.97 crore to ₹ 20.58 crore over 7 quarters. This represents a CAGR of -19.33%
The net profit of Ishita Drugs & Industries Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0%
The Dividend Payout of IOL Chemicals & Pharmaceuticals Ltd changed from 7.92 % on March 2021 to 23.25 % on March 2025 . This represents a CAGR of 24.03% over 5 yearsThe Dividend Payout of Ishita Drugs & Industries Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .
About IOL Chemicals & Pharmaceuticals Ltd
IOL Chemicals and Pharmaceuticals Limited, incorporated in September, 1986 is a renowned company in the Active Pharmaceutical
Ingredient (API) and specialty chemicals sectors.
Its extensive expertise in both API and specialty chemicals strengthens the business model and opens doors to diversified growth opportunities.
Within the API segment, IOL develops and supplies a wide range of essential products utilized by pharmaceutical companies worldwide for the production of key medicines.
It serves as a global supplier of various APIs, including Ibuprofen, Metformin, Clopidogrel, Lamotrigine, Pantoprazole, and Fenofibrate, alongside other APIs, and maintains a significant presence in all major therapeutic categories.
In the Specialty Chemicals division, IOL manufactures Ethyl Acetate, Iso Butyl Benzene (IBB), Mono Chloro Acetic Acid (MCA), and Acetyl Chloride.
About Ishita Drugs & Industries Ltd
Ishita Drugs & Industries Limited was incorporated in February, 1992 by Jagdish Agarwal.
The Company is engaged in the manufacture of various Activa Pharma Ingredients, drug intermediates, fine chemicals and excipient.
The company supplies its products to leading
pharmaceutical companies of India.
The products are also being exported to various countries across the world.
The plant has been designed and constructed to meet GMP norms.
The genesis of the Ishita Group in 1992 was the result of the entrepreneurial spirit of Mr. Jagdish Agrawal, who set up a reactive dye manufacturing unit in Ahmedabad.
FAQs for the comparison of IOL Chemicals & Pharmaceuticals Ltd and Ishita Drugs & Industries Ltd
Which company has a larger market capitalization, IOL Chemicals & Pharmaceuticals Ltd or Ishita Drugs & Industries Ltd?
Market cap of IOL Chemicals & Pharmaceuticals Ltd is 2,816 Cr while Market cap of Ishita Drugs & Industries Ltd is 24 Cr
What are the key factors driving the stock performance of IOL Chemicals & Pharmaceuticals Ltd and Ishita Drugs & Industries Ltd?
The stock performance of IOL Chemicals & Pharmaceuticals Ltd and Ishita Drugs & Industries Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.
What are the recent stock price for IOL Chemicals & Pharmaceuticals Ltd and Ishita Drugs & Industries Ltd?
As of May 6, 2026, the IOL Chemicals & Pharmaceuticals Ltd stock price is INR ₹95.95. On the other hand, Ishita Drugs & Industries Ltd stock price is INR ₹81.93.
How do dividend payouts of IOL Chemicals & Pharmaceuticals Ltd and Ishita Drugs & Industries Ltd compare?
To compare the dividend payouts of IOL Chemicals & Pharmaceuticals Ltd and Ishita Drugs & Industries Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.